{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:11:29Z","timestamp":1793171489159,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,2,25]],"date-time":"2012-02-25T00:00:00Z","timestamp":1330128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00125-012-2507-3","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T02:48:06Z","timestamp":1330051686000},"page":"1258-1264","source":"Crossref","is-referenced-by-count":58,"title":["Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature"],"prefix":"10.1007","volume":"55","author":[{"given":"J.-L.","family":"Richard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Almasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schuldiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,25]]},"reference":[{"key":"2507_CR1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cuor.2008.08.004","volume":"22","author":"JC Stanley","year":"2008","unstructured":"Stanley JC, Collier AM (2008) Charcot osteo-arthropathy. Curr Orthop 22:428\u2013433","journal-title":"Curr Orthop"},{"key":"2507_CR2","first-page":"257","volume-title":"Levin and O\u2019Neal\u2019s the diabetic foot","author":"LJ Sanders","year":"2007","unstructured":"Sanders LJ, Frykberg RG (2007) The Charcot foot (Pied de Charcot). In: Bowker JH, Pfeifer MA (eds) Levin and O\u2019Neal\u2019s the diabetic foot. Mosby Elsevier, Philadelphia, pp 257\u2013283"},{"key":"2507_CR3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jdiacomp.2008.09.004","volume":"23","author":"DK Wukich","year":"2009","unstructured":"Wukich DK, Sung W (2009) Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complications 23:409\u2013426","journal-title":"J Diabetes Complications"},{"key":"2507_CR4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.2337\/dc09-1428","volume":"33","author":"J Baal van","year":"2010","unstructured":"van Baal J, Hubbard R, Game F, Jeffcoate W (2010) Mortality associated with acute Charcot foot and neuropathic foot ulceration. Diabetes Care 33:1086\u20131089","journal-title":"Diabetes Care"},{"key":"2507_CR5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00125-002-0885-7","volume":"45","author":"RC Rajbhandari","year":"2002","unstructured":"Rajbhandari RC, Jenkins CD, Tesfaye S (2002) Charcot neuroarthropathy in diabetes mellitus. Diabetologia 45:1085\u20131096","journal-title":"Diabetologia"},{"key":"2507_CR6","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2337\/dc11-0844","volume":"34","author":"LC Rogers","year":"2011","unstructured":"Rogers LC, Frykberg RG, Armstrong DG et al (2011) The Charcot foot in diabetes. Diabetes Care 34:2123\u20132129","journal-title":"Diabetes Care"},{"key":"2507_CR7","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0140-6736(05)67029-8","volume":"366","author":"WJ Jeffcoate","year":"2005","unstructured":"Jeffcoate WJ, Game F, Cavanagh PR (2005) The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 366:2058\u20132061","journal-title":"Lancet"},{"key":"2507_CR8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/dmrr.837","volume":"24","author":"WJ Jeffcoate","year":"2008","unstructured":"Jeffcoate WJ (2008) Charcot neuro-osteoarthropathy. Diabetes Metab Res Rev 24:62\u201365","journal-title":"Diabetes Metab Res Rev"},{"key":"2507_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.diabet.2010.04.002","volume":"36","author":"L Molines","year":"2010","unstructured":"Molines L, Darmon P, Raccah D (2010) Charcot\u2019s foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab 36:251\u2013255","journal-title":"Diabetes Metab"},{"key":"2507_CR10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/(SICI)1096-9136(199707)14:7<527::AID-DIA404>3.0.CO;2-Q","volume":"7","author":"A Gough","year":"1997","unstructured":"Gough A, Abraha H, Li F et al (1997) Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic Charcot neuroarthropathy. Diabet Med 7:527\u2013531","journal-title":"Diabet Med"},{"key":"2507_CR11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00125-008-0992-1","volume":"51","author":"G Mabilleau","year":"2008","unstructured":"Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A (2008) Increased osteoclastic activity in acute Charcot\u2019s osteoarthropathy: the role of receptor activator of nuclear factor-\u03baB ligand. Diabetologia 51:1035\u20131040","journal-title":"Diabetologia"},{"key":"2507_CR12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1464-5491.1994.tb00225.x","volume":"11","author":"PL Selby","year":"1994","unstructured":"Selby PL, Young MJ, Boulton AJ (1994) Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 11:28\u201331","journal-title":"Diabet Med"},{"key":"2507_CR13","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.2337\/diacare.28.12.2962","volume":"28","author":"TA Lyn","year":"2005","unstructured":"Lyn TA, Greenstein A, Jarrett S, McGonagle D (2005) Acute neuropathic joint disease. A medical emergency? Diabetes Care 28:2962\u20132964","journal-title":"Diabetes Care"},{"key":"2507_CR14","first-page":"A92","volume":"48","author":"KB Stansberry","year":"1999","unstructured":"Stansberry KB, Moss QE, Peppard HR, McNitt PM, Vinik AI (1999) Intravenous bisphosphonate rapidly reverses the paradoxical increase in blood flow to the foot in Charcot neuroarthropathy. Diabetes 48:A92","journal-title":"Diabetes"},{"key":"2507_CR15","first-page":"1843","volume":"26","author":"S Guis","year":"1999","unstructured":"Guis S, Pellissier JF, Arniaud D et al (1999) Healing of Charcot\u2019s joint by pamidronate infusion. J Rheumatol 26:1843\u20131845","journal-title":"J Rheumatol"},{"key":"2507_CR16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1520-7560(199901\/02)15:1<59::AID-DMRR4>3.0.CO;2-T","volume":"15","author":"MT Young","year":"1999","unstructured":"Young MT (1999) The management of neurogenic arthropathy: a tale of two Charcots. Diabetes Metab Res Rev 15:59\u201364","journal-title":"Diabetes Metab Res Rev"},{"key":"2507_CR17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/145749690209100212","volume":"9","author":"T-K Pakarinen","year":"2002","unstructured":"Pakarinen T-K, Laine H-J, Honkonnen SE, Peltonen J, Oksala H, Lahtela J (2002) Charcot arthropathy of diabetic foot: current concepts and review of 36 cases. Scand J Surg 9:195\u2013201","journal-title":"Scand J Surg"},{"key":"2507_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1699-258X(07)73700-2","volume":"3","author":"M Moreno","year":"2007","unstructured":"Moreno M, Gratac\u00f3s J, Casado E, Galisteo C, Orellana C, Larrosa M (2007) Utilidad del pamidronato en el tratamiento de la artropat\u00eda de Charcot (Usefulness of pamidronate in the treatment of Charcot\u2019s arthropathy). Reumatol Clin 3:257\u2013261, article in Spanish","journal-title":"Reumatol Clin"},{"key":"2507_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MAJ.0b013e3180a5e957","volume":"335","author":"A Naqvi","year":"2008","unstructured":"Naqvi A, Cuchacovich R, Saketkoo L, Espinoza LR (2008) Acute Charcot arthropathy successfully treated with Pamidronate: long-term follow-up. Am J Med Sci 335:145\u2013148","journal-title":"Am J Med Sci"},{"key":"2507_CR20","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1053\/j.jfas.2004.07.005","volume":"43","author":"JJ Anderson","year":"2004","unstructured":"Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM (2004) Bisphophonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg 43:2285\u20132289","journal-title":"J Foot Ankle Surg"},{"key":"2507_CR21","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s001250100008","volume":"44","author":"EB Jude","year":"2001","unstructured":"Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB et al (2001) Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 44:2032\u20132037","journal-title":"Diabetologia"},{"key":"2507_CR22","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diacare.28.5.1214","volume":"28","author":"D Pitocco","year":"2005","unstructured":"Pitocco D, Ruotolo V, Caputo S et al (2005) Six-month treatment with Alendronate in acute Charcot neuroarthropathy. Diabetes Care 28:1214\u20131215","journal-title":"Diabetes Care"},{"key":"2507_CR23","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/dc11-0396","volume":"34","author":"T-K Pakarinen","year":"2011","unstructured":"Pakarinen T-K, Laine H-J, M\u00e4enp\u00e4\u00e4 H, Mattila P, Lahtela J (2011) The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy. A pilot randomized controlled trial. Diabetes Care 34:1514\u20131516","journal-title":"Diabetes Care"},{"key":"2507_CR24","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1210\/jc.2007-0646","volume":"92","author":"D Vega","year":"2007","unstructured":"Vega D, Maalouf NM, Sakhaee K (2007) The role of receptor activator of nuclear factor-\u03baB (RANK)\/RANK ligand\/osteoprotegerin: clinical implications. J Clin Endocrinol Metab 92:4514\u20134521","journal-title":"J Clin Endocrinol Metab"},{"key":"2507_CR25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/dc09-1141","volume":"33","author":"L Uccioli","year":"2010","unstructured":"Uccioli L, Sinistro A, Almerighi C et al (2010) Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot. Diabetes Care 33:350\u2013355","journal-title":"Diabetes Care"},{"key":"2507_CR26","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2337\/dc09-0243","volume":"32","author":"D Pitocco","year":"2009","unstructured":"Pitocco D, Zelano G, Gioffr\u00e9 G et al (2009) Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic Charcot neuroarthropathy. A case\u2013control study. Diabetes Care 32:1694\u20131697","journal-title":"Diabetes Care"},{"key":"2507_CR27","doi-asserted-by":"crossref","unstructured":"Korzon-Burakowska A, Jak\u00f3bkiewicz-Banecka J, Fiedosiuk A et al (2011) Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. Diabet Med. doi: 10.1111\/j.1464-5491.2011.03442.x","DOI":"10.1111\/j.1464-5491.2011.03442.x"},{"key":"2507_CR28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/107110070602700503","volume":"27","author":"MS Pinzur","year":"2006","unstructured":"Pinzur MS, Lio T, Posner M (2006) Treatment of Eichenholtz stage 1 Charcot foot arthropathy with a weightbearing total contact cast. Foot Ankle Int 27:324\u2013329","journal-title":"Foot Ankle Int"},{"key":"2507_CR29","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E","volume":"44","author":"JC Frith","year":"2001","unstructured":"Frith JC, M\u00f6nkk\u00f6nen J, Auriola S, M\u00f6nkk\u00f6nen H, Rogers MJ (2001) The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum 44:2201\u20132210","journal-title":"Arthritis Rheum"},{"key":"2507_CR30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RGG Russell","year":"2008","unstructured":"Russell RGG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19:733\u2013759","journal-title":"Osteoporos Int"},{"key":"2507_CR31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1568014024606539","volume":"1","author":"WP Maksymowych","year":"2002","unstructured":"Maksymowych WP (2002) Bisphosphonates\u2014anti-inflammatory properties. Curr Med Chem Anti Inflamm Anti Allergy Agents 1:15\u201328","journal-title":"Curr Med Chem Anti Inflamm Anti Allergy Agents"},{"key":"2507_CR32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1479-6988.2007.00081.x","volume":"5","author":"C Smith","year":"2007","unstructured":"Smith C, Kumar S, Causby R (2007) The effectiveness of non-surgical interventions in the treatment of Charcot foot. Int J Evid Based Healthc 5:437\u2013449","journal-title":"Int J Evid Based Healthc"},{"key":"2507_CR33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00125-011-2354-7","volume":"55","author":"FL Game","year":"2012","unstructured":"Game FL, Catlow R, Jones GR, Edmonds ME, Jude EB, Rayman G, Jeffcoate WJ (2012) Audit of acute Charcot\u2019s disease in the UK: the CDUK study. Diabetologia 55:32\u201335","journal-title":"Diabetologia"},{"key":"2507_CR34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032\u20131045","journal-title":"Mayo Clin Proc"},{"key":"2507_CR35","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/dc06-0376","volume":"29","author":"R Bem","year":"2006","unstructured":"Bem R, Jirkovsk\u00e1 A, Fejfarov\u00e1 V, Skibov\u00e1 J, Jude EB (2006) Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy. A randomized clinical trial. Diabetes Care 29:1392\u20131394","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2507-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-012-2507-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2507-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T05:50:39Z","timestamp":1561355439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-012-2507-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,25]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["2507"],"URL":"https:\/\/doi.org\/10.1007\/s00125-012-2507-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,25]]}}}